RSS Feed For (NASDAQ:XOMA)

XOMA (NASDAQ:XOMA)

0.74 0.05 (6.33%)
XOMA (NASDAQ:XOMA) Delayed :
Previous Close $0.79    52 Week High $1.34 
Open $0.70    52 Week Low $0.37 
Day High $0.76    P/E N/A 
Day Low $0.70    EPS $0.00 
Volume 2,420,049       
More XOMA Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
LSCC 3 CROX 3
MW 3 ERII 3
FSYS 3 CBS 2
FTWR 2 KOG 2
GE 2 LSCC 2
AXYS 2 MW 2
View All Friends, Peers and Foes

View All Major News StreetInsider.com Major News for XOMA

Nov 9, 2009 08:21 AM XOMA (XOMA) Posts Q3 EPS of $0.01, Misses by 1c
Aug 6, 2009 04:14 PM XOMA (XOMA) Reports Q2 Loss of $0.07, Beats by 2c
May 7, 2009 04:51 PM XOMA (XOMA) Tops Q1 Views
View All Major News

StreetInsider Reports on XOMA by Category

View All Comments Comments on recent XOMA articles

Michael
on Nov 12, 2009
at 07:54 PM
Monoclonal Antibodies for Type 2 Diabetes I will be retiring early, thanks to XOMA. What's even better, if I contract Diabetes Type II when I reach 60, being a little overweight, I will live a long life without the need for daily insulin injections. XOMA 052 will change the treatment of all forms of diabetes, as we know it.
Article: XOMA (XOMA) Falls Modestly Following After-Hours Downgrade
BioInvestor
on Nov 10, 2009
at 09:20 AM
The Diabetes Market Outlook A once monthly or even every 3 month, tiny shot to control blood-sugar in Diabetes Type I & II patients. Are you kidding me, this company is a steal at this price. The upside is well into the $55 range with big pharma serving up daily insulin shots over the last 10yrs. Unbelievable cheap stock will take care of my retirement.
Article: XOMA (XOMA) Posts Q3 EPS of $0.01, Misses by 1c
Francesco
on Nov 9, 2009
at 12:32 PM
some hope I waited patiantly for 20 years since I purchessed Xoma at 15.75, I hope the good news will drive the stock up....
Article: XOMA (XOMA) Posts Q3 EPS of $0.01, Misses by 1c
Michael M
on Nov 3, 2009
at 11:31 AM
XOMA is a great company. They haven't announced their new patent, but I think this week it will come and the new military applications of an injectable biodefense delivery for military applications. $$ Title: Method of treating or preventing an IL-1 related disease or condition Patent ID: US7582742 Issue Date: September 01, 2009 !!!!!! :) Assignee: XOMA Technology Ltd. (Berkeley, CA)
Article: XOMA (XOMA) and Kaketsuken Enter Into Collaboration for Antibody Research and Development Technologies
Michael
on Oct 14, 2009
at 10:32 AM
mbmalone_2000@yahoo.com Type 2 diabetes patients have long sought improved treatment options that go beyond glucose management and frequent insulin injections. Current approaches force more insulin out of 'tired' pancreatic beta cells or make peripheral cells more sensitive to insulin, whereas XOMA 052 targets the actual inflammation mechanism. Showing an increase in insulin production three months after a single infusion is remarkable, we could have a disease-modifying therapy in a single dose of XOMA 052 with positive biological activity and duration of effect ... and it's well tolerated. ZOMA has a blockbuster drug and Engel's knows it!
Article: XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
View All Comments

Comments on XOMA


No comments are currently available.